D ESPITE ITS well-known sensitivity to anthracyclines,[1-5][1] acute promyelocytic leukemia (APL) was catalogued until the late 1980s as one of the most rapidly fatal human tumors, with the majority of patients dying early of intractable hemorrhage or disease relapse.[6][2] Two major research
No takes yet. Share an insight, caveat, or question.
Lo‐Coco et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: